Intrua Financial’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,487
Closed -$432K 469
2025
Q4
$432K Hold
2,487
0.05% 289
2025
Q3
$474K Hold
2,487
0.05% 262
2025
Q2
$447K Sell
2,487
-125
-5% -$21.7K 0.06% 227
2025
Q1
$442K Hold
2,612
0.06% 222
2024
Q4
$394K Sell
2,612
-29
-1% -$4.51K 0.06% 236
2024
Q3
$410K Sell
2,641
-76
-3% -$11.3K 0.06% 258
2024
Q2
$372K Hold
2,717
0.06% 275
2024
Q1
$362K Sell
2,717
-767
-22% -$99.5K 0.05% 288
2023
Q4
$480K Buy
3,484
+2
+0.1% +$263 0.07% 236
2023
Q3
$424K Hold
3,482
0.07% 218
2023
Q2
$489K Hold
3,482
0.08% 200
2023
Q1
$455K Sell
3,482
-40
-1% -$5.72K 0.09% 196
2022
Q4
$512K Hold
3,522
0.12% 183
2022
Q3
$432K Sell
3,522
-1,500
-30% -$198K 0.12% 184
2022
Q2
$668K Sell
5,022
-1,645
-25% -$224K 0.14% 154
2022
Q1
$912K Sell
6,667
-28
-0.4% -$3.9K 0.16% 129
2021
Q4
$1.16M Sell
6,695
-8
-0.1% -$1.22K 0.2% 113
2021
Q3
$965K Buy
6,703
+1,760
+36% +$258K 0.18% 121
2021
Q2
$734K Buy
4,943
+120
+2% +$15.7K 0.18% 125
2021
Q1
$638K Buy
4,823
+996
+26% +$123K 0.16% 135
2020
Q4
$456K Hold
3,827
0.2% 103
2020
Q3
$465K Buy
3,827
+90
+2% +$10.6K 0.23% 96
2020
Q2
$455K Buy
+3,737
New +$396K 0.17% 120

Other funds holding DGX

Intrua Financial's DGX Position: Q1 2026 in Review

Intrua Financial sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 2,487 shares — an estimated $432K sold.

Intrua Financial first reported a position in DGX in Q2 2020 and held it in 23 quarters. The position peaked at $1.16M in Q4 2021. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Intrua Financial reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Intrua Financial sold 2,487 Quest Diagnostics shares in Q1 2026, an estimated $432K.
  • Intrua Financial first reported a position in Quest Diagnostics in Q2 2020 and held it in 23 quarters.
  • Intrua Financial's Quest Diagnostics position peaked at $1.16M in Q4 2021.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Intrua Financial's 13F filing for Q1 2026, filed 23 Apr 2026.